Diese Veranstaltung hat bereits stattgefunden.
Folgende kommende Veranstaltungen könnten Sie interessieren:
| 28.01.2021 | Dry Eye Disease (DED) |
| 09.02.2021 | Medical Retina |
| 30.03.2021 | Medical Retina |
| 10.05.2021 | Basic Cataract and Intraocular Refractive Surgery |
| 21.06.2021 | Intermediate and Advanced Surgical Retina |
Medical Retina
Rome, Italien
Lehrkurs
Medical Retina
3rd ESASO Module 2019
Datum:
25.02.2019, 07:45 - 01.03.2019, 12:20
Veranstalter:
European School for Advanced Studies in Ophthalmology ESASO
Kurzbeschreibung:
This 3rd module of the ESASO training courses in 2019 will focus on medical retina. International speakers will share their knowledge. The training course will take place in Rome, Italy.
Fortbildungspunkte: 25
Hinweis:
An application will be made to EACCME® for CME accreditation of this event.
Fachärzte
Max. Teilnehmer: unbegrenzt
Gebühren ab: 2.300,00 EUR
Hinweis:
Accomodation included
Gebühren ab: 2.300,00 EUR
Hinweis:
Accomodation included
Ärzte/-innen in Weiterbildung
Max. Teilnehmer: unbegrenzt
Gebühren ab: 2.300,00 EUR
Hinweis:
Accomodation included.
Gebühren ab: 2.300,00 EUR
Hinweis:
Accomodation included.
Bemerkungen:
Diese Veranstaltung findet jährlich statt und bietet Fortbildungsmöglichkeiten für Fachärzte und Ärzte/-innen in Weiterbildung.
Die Zertifizierung wurde von der European Accreditation Council for Continuing Medical Education (EACCME) genehmigt.
Veranstaltungsnummer: 25970
Zertifizierung: genehmigt
CME Max.: 25
Gebühren ab: ab 2.300,00
verfügbare Plätze: unbegrenzt
Sprache: Englisch
Vom Veranstalter gemeldetes Programm:
| MONDAY, 25 FEBRUARY 2019 | |
| 07:45 | Registration and welcoming |
| NEW DIAGNOSTIC AND TREATMENT FOR DR | |
| 08:30 | Stadiation of DR on Wide-Field imaging |
| 09:00 | Modification of the signs of DR on Wide-Field imaging following intravitreal treatment |
| 09:30 | OCT-A for Diabetic Retinopathy |
| 10:00 | Controversial point: the fluorescein angiography is still necessary for the diagnosis and stadiation of DR |
| 10:30 | COFFEE BREAK |
| 11:00 | Controversial point: No more fluorescein angiography for the diagnosis and stadiation of DR |
| 11:30 | New paradigms of treatment of PDR |
| 12:00 | Cases Study: PDR treatment |
| 12:30 | LUNCH |
| DECISION MAKING IN THE TREATMENT OF DME | |
| 13:30 | The identification of inflammatory biomarkers and their prognostic value |
| 14:00 | Differentiate DME vs AMD |
| 14:30 | Patients management with focus on inflammation and number of injections |
| 15:00 | Real life data on DME intravitreal treatments |
| 15:30 | COFFEE BREAK |
| 16:20 | Controversial point: Monthly intravitreal injections of anti-VEGF remain the first choice treatment of DME |
| 16:40 | Controversial point: A long-standing disease, as DME, needs a long lasting treatment |
| 17:00 | DME treatment: case study |
| TUESDAY, 26 FEBRUARY 2019 | |
| 08:30 | Discerning the severity of dry AMD |
| 12:30 | LUNCH |
| OCULAR COMPLICATIONS OF IV TREATMENT: RARE BUT REAL | |
| 13:30 | Rhegmatogenous retinal detachment following intravitreal treatment: risk factors and outcomes |
| 14:00 | Endophthalmitis and sterile endophthalmitis following intravitreal treatment: diagnosis and treatment |
| 15:00 | COFFEE BREAK |
| 15:30 | Cataract, Glaucoma and other complications |
| 16:00 | Geographic atrophy secondary to intravitreal anti-VEGF treatment |
| WEDNESDAY, 27 FEBRUARY 2019 | |
| AMD | |
| 08:30 | Discerning the severity of dry AMD |
| 09:00 | Diagnosis and natural progression of geographic atrophy, actual and future management |
| 09:45 | Nanoseconds and other lasers in Dry-AMD, mechanism of action, techniques, results |
| 10:30 | COFFEE BREAK |
| 11:00 | OCT-A features of Wet-AMD at baseline |
| 11:45 | Cases Study of Wet AMD management |
| 12:30 | LUNCH |
| 13:30 | Incoming new treatments for Wet-AMD |
| 14:00 | Cases Study of PCV management |
| 14:45 | COFFEE BREAK |
| 15:15 | Identification and classification of fibrosis in AMD |
| 15:45 | Cases study of exit strategy in the treatment of Wet-AMD |
| THURSDAY, 28 FEBRUARY 2019 | |
| MIOPIC MACULAR DEGENERATION CLINICAL PRACTICE COURSE | |
| 08:30 | Morphology of the myopic macula and detection of its components |
| 09:00 | Features of myopic macular CNV at baseline and of the characteristics associated with good or bad visual acuity outcomes |
| 09:45 | Cases Study of Myopic CNV management |
| 10:30 | COFFEE BREAK |
| 11:00 | Long-term outcomes of myopic CNV intravitreal treatment |
| 11:30 | Controversial point: the intravitreal treatment of MMD must be guided first by morphological aspects |
| 12:00 | Controversial point: the intravitreal treatment of MMD must be guided first by visual acuity changes |
| 12:30 | LUNCH |
| RVO CLINICAL PRACTICE COURSE | |
| 13:30 | Features of RVO at baseline and of the characteristics associated with good or bad visual acuity outcomes |
| 14:30 | Protocols of treatment and long-term outcomes |
| 15:00 | COFFEE BREAK |
| 15:30 | Cases Study of RVO management |
| 16:00 | The role of inflammation in RVO |
| 16:30 | The utility of systemic and other therapies in RVO |
| FRIDAY, 1st MARCH 2019 | |
| OCT-A ESSENTIAL | |
| 08:30 | OCT Angiography to differentiate intraretinal microvascular abnormalities (IRMA) from retinal neovascularization (RNV) |
| 08:50 | OCT angiography to differentiate collateral vessels in ischemic retinal vein occulsion |
| 09:10 | OCT Angiography to detect non-exudative choroidal neovascularization and vascularized drusen |
| 09:30 | OCT angiography to detect and monitor Quiescent Exudative AMD with persistent subretinal fluid |
| 09:50 | OCT Angiography to detect macular microvascular changes in patients with no evidence of diabetic retinopathy |
| 10:10 | COFFEE BREAK |
| 10:40 | OCT Angiography to detect AMD mimicking CSC and reverse |
| 11:00 | OCT Angiography to detect and differentiate a Mac-Tel from other intraretinal microvascular abnormalities |
| 11:20 | OCT Angiography to detect and differentiate ischemic optic neuritis from papilledema |
| 11:40 | OCT Angiography to detect and differentiate optic disc collateral vessel from neovascularization of the optic disc |
| 12:00 | OCT Angiography to detect haller and sattler layers alterations |
| 12:20 | Final Test and Farewell |
Veranstaltungsort:
tba
Anschrift:
Rome, Italien
Veranstalter:
European School for Advanced Studies in Ophthalmology ESASO
Organisation:
European School for Advanced Studies in Ophthalmology ESASO
c/o Università della Svizzera italiana (USI)
Via G. Buffi 13
CH - 6904 Lugano
Tel.: +41 (0)58 666 46 29
Fax: +41 (0)58 666 46 19
Hinweis:
Registration required. Please contact the organizer for further information.